FlumequineCAS# 42835-25-6 |
- Etifoxine
Catalog No.:BCC1560
CAS No.:21715-46-8
- Etomidate
Catalog No.:BCC1150
CAS No.:33125-97-2
- Etifoxine hydrochloride
Catalog No.:BCC1561
CAS No.:56776-32-0
- Acamprosate calcium
Catalog No.:BCC1327
CAS No.:77337-73-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 42835-25-6 | SDF | Download SDF |
| PubChem ID | 3374 | Appearance | Powder |
| Formula | C14H12FNO3 | M.Wt | 261.25 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : 7.69 mg/mL (29.44 mM; Need ultrasonic) | ||
| SMILES | CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2)F)C(=O)O | ||
| Standard InChIKey | DPSPPJIUMHPXMA-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Flumequine is a quinolone antibiotic, and acts as a topoisomerase II inhibitor, with an IC50 of 15 μM (3.92 μg/mL).In Vitro:Flumequine is a topoisomerase II inhibitor, with an IC50 of 3.92 μg/mL, and less potently inhibits Gyrase, with an IC50 of 1764 μg/mL. Flumequine (0-625 μg/mL) increases migration of nuclear DNA from CHL cells[1]. Flumequine inhibits Spanish field isolates of B. hyodysenteriae with MIC50 and MIC90 of 50 and 100 μg/mL, and MBC50 and MBC90 of 50, 200 μg/mL, respectively[2]. Flumequine suppresses A. salmonicida isolates with MIC ranging from 0.06 to 32 μg/mL[3].In Vivo:Flumequine (0-500 mg/kg, p.o.) causes dose-related DNA damage in the stomach, colon, and urinary bladder of mice, 1 and 3 h but not 24 h after its administration[1]. References: | |||||
Flumequine Dilution Calculator
Flumequine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.8278 mL | 19.1388 mL | 38.2775 mL | 76.555 mL | 95.6938 mL |
| 5 mM | 0.7656 mL | 3.8278 mL | 7.6555 mL | 15.311 mL | 19.1388 mL |
| 10 mM | 0.3828 mL | 1.9139 mL | 3.8278 mL | 7.6555 mL | 9.5694 mL |
| 50 mM | 0.0766 mL | 0.3828 mL | 0.7656 mL | 1.5311 mL | 1.9139 mL |
| 100 mM | 0.0383 mL | 0.1914 mL | 0.3828 mL | 0.7656 mL | 0.9569 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Flumequine is a synthetic chemotherapeutic antibiotic, inhibiting topoisomerase II with IC50 of 15 μM.
- Catechin 7-xyloside
Catalog No.:BCN5484
CAS No.:42830-48-8
- Shinjulactone L
Catalog No.:BCN7958
CAS No.:4283-49-2
- H-N-Me-Leu-OBzl.TosOH
Catalog No.:BCC3215
CAS No.:42807-66-9
- Magnoflorine Iodide
Catalog No.:BCN2911
CAS No.:4277-43-4
- D-Valinol
Catalog No.:BCC2693
CAS No.:4276-09-9
- 2-Aminophenyl phenyl sulfone
Catalog No.:BCC8554
CAS No.:4273-98-7
- Pedunculoside
Catalog No.:BCN1191
CAS No.:42719-32-4
- Cyproterone Acetate
Catalog No.:BCC3758
CAS No.:427-51-0
- S-Isopropylisothiourea hydrobromide
Catalog No.:BCC6837
CAS No.:4269-97-0
- NS 5806
Catalog No.:BCC7872
CAS No.:426834-69-7
- 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside
Catalog No.:BCN1442
CAS No.:426821-85-4
- Hemapolin
Catalog No.:BCC8994
CAS No.:4267-80-5
- Flumequine sodium
Catalog No.:BCC8985
CAS No.:42835-68-7
- H-Ala-OBzl.TosOH
Catalog No.:BCC3191
CAS No.:42854-62-6
- 2-(3-Benzoylphenyl)propionitrile
Catalog No.:BCC8479
CAS No.:42872-30-0
- For-Met-OH
Catalog No.:BCC2992
CAS No.:4289-98-9
- 14-Deoxy-11,12-didehydroandrographolide
Catalog No.:BCN1441
CAS No.:42895-58-9
- Santamarine
Catalog No.:BCN5485
CAS No.:4290-13-5
- Tilianin
Catalog No.:BCN3669
CAS No.:4291-60-5
- Cladribine
Catalog No.:BCC1173
CAS No.:4291-63-8
- Z-Abu-OH
Catalog No.:BCC3201
CAS No.:42918-86-5
- Nabumetone
Catalog No.:BCC4434
CAS No.:42924-53-8
- Dabigatran ethyl ester
Catalog No.:BCC1512
CAS No.:429658-95-7
- Cathepsin G Inhibitor I
Catalog No.:BCC3598
CAS No.:429676-93-7
Evaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriae.[Pubmed:26679795]
Res Vet Sci. 2015 Dec;103:51-3.
Flumequine is a quinolone derivative used in veterinary medicine to treat enteric infections, mainly those caused by Gram negative bacteria and also some Gram positive. Some recent reports by field practitioners have suggested that its use in swine dysentery outbreaks can minimize the impact of this disease. This study aims to evaluate the in vitro anti-Brachyspira hyodysenteriae activity of Flumequine. Forty eight field isolates of the bacterium were evaluated using a microdilution test. The lack of colon bioavailability studies of Flumequine in pigs makes it difficult to establish the true efficacy of this antibiotic for swine dysentery control. Nonetheless, the relatively high values of MIC50 (50 mug/mL) and MBC50 (50 mug/mL) obtained suggest poor activity against B. hyodysenteriae. Flumequine activity in swine dysentery outbreaks could be related to its activity against other bacteria, different from B. hyodysenteriae, engaged in swine dysentery pathogenesis.
Validation of a Chiral Liquid Chromatographic Method for the Degradation Behavior of Flumequine Enantiomers in Mariculture Pond Water.[Pubmed:27483447]
Chirality. 2016 Sep;28(9):649-55.
In this work, Flumequine (FLU) enantiomers were separated using a Chiralpak OD-H column, with n-hexane-ethanol (20:80, v/v) as the mobile phase at a flow rate of 0.6 mL/min. Solid phase extraction (SPE) was used for cleanup and enrichment. The limit of detection, limit of quantitation, linearity, precision, and intra/interday variation of the chiral high-performance liquid chromatography (HPLC) method were determined. The developed method was then applied to investigate the degradation behavior of FLU enantiomers in mariculture pond water samples. The results showed that the degradation of FLU enantiomers under natural, sterile, or dark conditions was not enantioselective. Chirality 28:649-655, 2016. (c) 2016 Wiley Periodicals, Inc.
Use of micellar liquid chromatography to analyze oxolinic acid, flumequine, marbofloxacin and enrofloxacin in honey and validation according to the 2002/657/EC decision.[Pubmed:26920300]
Food Chem. 2016 Jul 1;202:316-23.
A micellar liquid chromatographic method was developed for the analysis of oxolinic acid, Flumequine, marbofloxacin and enrofloxacin in honey. These quinolines are unethically used in beekeeping, and a zero-tolerance policy to antibiotic residues in honey has been stated by the European Union. The sample pretreatment was a 1:1 dilution with a 0.05M SDS at pH 3 solution, filtration and direct injection, thus avoiding extraction steps. The quinolones were eluted without interferences using mobile phase of 0.05M SDS/12.5% 1-propanol/0.5% triethylamine at pH 3, running at 1mL/min under isocratic room through a C18 column. The analytes were detected by fluorescence. The method was successfully validated according to the requirements of the European Union Decision 2002/657/EC in terms of: specificity, linearity (r(2)>0.995), limit of detection and decision limit (0.008-0.070mg/kg), lower limit of quantification (0.02-0.2mg/kg), detection capability (0.010-0.10mg/kg), recovery (82.1-110.0%), precision (<9.4%), matrix effects, robustness (<10.4%), and stability. The procedure was applied to several commercial honey supplied by a local supermarket, and the studied antibiotics were not detected. Therefore, the method was rapid, simple, safe, eco friendly, reliable and useful for the routine analysis of honey samples.
Analysis of flumequine enantiomers in rat plasma by UFLC-ESI-MS/MS.[Pubmed:27791319]
Chirality. 2016 Nov;28(11):737-743.
In this study the analysis and confirmation of Flumequine enantiomers in rat plasma by ultra-fast liquid chromatography coupled with electron spray ionization mass spectrometry (using propranolol as an internal standard [IS]) was developed and validated. Plasma samples were prepared by liquid-liquid extraction using methyl tert-butyl ether as the extraction solvent. Direct resolution of the R- and S-isomers was performed on a CHIRALCEL OJ-RH column (4.6 x 150 mm, 5 mum) using acetonitrile / 0.1% formic acid / 1 mM ammonium acetate as the mobile phase. Detection was operated by electron spray ionization in the selected ion monitoring and positive ion mode. The target ions at m/z 262.1 and m/z 260.1 were selected for the quantification of the enantiomers and IS, respectively. The linear range was 0.5-500 ng/mL. The precisions (coefficient of variation, CV%) and recoveries were 1.43-8.68 and 94.24-106.76%, respectively. The lowest quantitation limit for both enantiomers is 0.5 ng/mL, which is sensitive enough to be applied to sample analysis in other related studies.
